Tobramycin in the neonatal period.
D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000097:blood / Q000134:cerebrospinal fluid / Q000627:therapeutic use*; D001419:Bacteria / Q000187:drug effects; D002986:Clinical Trials as Topic; D004352:Drug Resistance, Microbial; D006207:Half-Life; D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000188:drug therapy; D008581:Meningitis / Q000188:drug therapy; D018805:Sepsis
D000900:Anti-Bacterial Agents